Kwaliteitsstandaard Primaire Scleroserende Cholangitis (PSC)

Kwaliteitsstandaard PSC Pagina 89 van 117 Versie 1.0 13. Beuers U, Spengler U, Kruis W, Aydemir U, Wiebecke B, Heldwein W. et al. Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo- controlled trial. Hepatology. 1992; 16: 707714 14. Bjornsson, E., Lindqvist-Ottosson, J., Asztely, M., and Olsson, R. Dominant strictures in patients with primary sclerosing cholangitis. Am J Gastroenterol. 2004; 99 15. Blechacz B, Gores GJ . Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology 2008; 48: 308-321 16. Blauwdruk Participeren in Richtlijnen: leidraad voor het effectief opnemen van “participeren en functioneren in werk”; website NVAB; NVAB, CBO, VGI. 17. Boberg, K.M., Egeland, T., and Schrumpf, E. Long-term effect of corticosteroid treatment in primary sclerosing cholangitis patients. Scand J Gastroenterol. 2003; 38 18. Boberg, K.M., Jebsen, P., Clausen, O.P., Foss, A., Aabakken, L., and Schrumpf, E. Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis. J Hepatol. 2006; 45: 568574 19. Bonkovsky HL, Hawkins M, Steinberg K, Hersh T, Galambos JT, Henderson JM, Millikan WJ, Galloway JR. Prevalence and prediction of osteopenia in chronic liver disease. Hepatology. 1990 Aug;12(2):273-80. 20. Boonstra K, Ponsioen CIJ, Rauws EAJ, Beuers U. Primaire scleroserende cholangitis: Stand van zaken. Ned Tijdschr Geneeskd. 2010; 154:A1476. 21. Boonstra K, Weersma RK, van Erpecum KJ, Rauws EA, Spanier BW, Poen AC, et al. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis. Hepatology. 2013 Dec;58(6):2045-2055. 22. Broome, U. and Bergquist, A. Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer. Semin Liver Dis. 2006; 26: 3141 23. Buiting C, Njoo K. Richtlijn Informatie-uitwisseling tussen Huisarts en Specialist bij verwijzingen (HASP). 2008 Nederlands Huisartsen Genootschap. 24. Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B, et al. AASLD Practice Guidelines; Diagnosis and management of Primary Sclerosing Cholangitis. Hepatology. 2010 Feb;51(2):660-678. 25. Charatcharoenwitthaya, P., Enders, F.B., Halling, K.C., and Lindor, K.D. Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis. Hepatology. 2008; 48: 11061117